Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V9MR
|
|||
| Drug Name |
XL888
|
|||
| Synonyms |
5-((R)-sec-Butylamino)-N1-(8-(5-(cyclopropanecarbonyl)pyridin-2-yl)-8-azabicyclo[3.2.1]octan-3-yl)-2-methylterephthalamide; SCHEMBL2425587; CHEMBL2204502; MolPort-035-395-767; EX-A1668; s7122; AKOS027253610; NCGC00386261-01; HY-13313; KB-81507; SC-95577; CS-0003194; SW219489-1
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Gastrointestinal cancer [ICD-11: 2C11] | Phase 1 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H37N5O3
|
|||
| Canonical SMILES |
CCC(C)NC1=C(C=C(C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C)C(=O)N
|
|||
| InChI |
1S/C29H37N5O3/c1-4-17(3)32-25-14-23(16(2)11-24(25)28(30)36)29(37)33-20-12-21-8-9-22(13-20)34(21)26-10-7-19(15-31-26)27(35)18-5-6-18/h7,10-11,14-15,17-18,20-22,32H,4-6,8-9,12-13H2,1-3H3,(H2,30,36)(H,33,37)/t17-,20?,21?,22?/m1/s1
|
|||
| InChIKey |
LHGWWAFKVCIILM-LAQKFSSHSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03095781) Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.